Updated: 24 November 2025

Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

24 November 2025

Must Read

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.

Source link

Premier League highlights: Manchester United 0-1 Everton

Bitcoin miners squeezed by record hashrate even as sector stocks jump

- Advertisement -

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here

- Advertisement -

Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

LEAVE A REPLY Cancel reply

The Best Holiday Gift Is Something You Can Eat

36 Holiday Gifts From Coach, SSENSE, New Balance, The North Face, Kate Spade, and Saks

Navy Cancels Future Constellation-Class Frigates, Raising Fleet Size Concerns

Mapping the Brain’s Sense of What Goes On Inside the Body

BitMEX Launches the ‘BitMEX Legends’ Campaign With a 5 BTC Prize Pool to Celebrate 11-Year Anniversary

More Articles Like This

Category

Links

Stay connected

Mail us : thetimes365@thetimes365.com

Newsletter Signup